As of 2025-11-02, the Relative Valuation of Vir Biotechnology Inc (VIR) is (64.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.96 USD, the upside of Vir Biotechnology Inc based on Relative Valuation is -1183.2%.
The range of the Relative Valuation is (62.74) - (68.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 17.3x | 17.2x |
| Forward P/E multiples | 13.6x - 18.6x | 15.4x |
| Fair Price | (62.74) - (68.44) | (64.56) |
| Upside | -1152.7% - -1248.4% | -1183.2% |
| Date | P/E |
| 2025-10-30 | -1.50 |
| 2025-10-29 | -1.49 |
| 2025-10-28 | -1.62 |
| 2025-10-27 | -1.56 |
| 2025-10-24 | -1.51 |
| 2025-10-23 | -1.46 |
| 2025-10-22 | -1.55 |
| 2025-10-21 | -1.58 |
| 2025-10-20 | -1.58 |
| 2025-10-17 | -1.46 |
| 2025-10-16 | -1.46 |
| 2025-10-15 | -1.53 |
| 2025-10-14 | -1.44 |
| 2025-10-13 | -1.48 |
| 2025-10-10 | -1.46 |
| 2025-10-09 | -1.52 |
| 2025-10-08 | -1.53 |
| 2025-10-07 | -1.43 |
| 2025-10-06 | -1.41 |
| 2025-10-03 | -1.45 |
| 2025-10-02 | -1.43 |
| 2025-10-01 | -1.44 |
| 2025-09-30 | -1.44 |
| 2025-09-29 | -1.42 |
| 2025-09-26 | -1.39 |
| 2025-09-25 | -1.31 |
| 2025-09-24 | -1.33 |
| 2025-09-23 | -1.31 |
| 2025-09-22 | -1.33 |
| 2025-09-19 | -1.31 |
| 2025-09-18 | -1.31 |
| 2025-09-17 | -1.21 |
| 2025-09-16 | -1.23 |
| 2025-09-15 | -1.21 |
| 2025-09-12 | -1.26 |
| 2025-09-11 | -1.32 |
| 2025-09-10 | -1.30 |
| 2025-09-09 | -1.32 |
| 2025-09-08 | -1.31 |
| 2025-09-05 | -1.33 |
| 2025-09-04 | -1.30 |
| 2025-09-03 | -1.39 |
| 2025-09-02 | -1.26 |
| 2025-08-29 | -1.25 |
| 2025-08-28 | -1.27 |
| 2025-08-27 | -1.32 |
| 2025-08-26 | -1.12 |
| 2025-08-25 | -1.11 |
| 2025-08-22 | -1.16 |
| 2025-08-21 | -1.11 |